These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1366624)

  • 21. [Use of monoclonal antibodies in the immunotherapy of neoplasms].
    Robak T
    Przegl Lek; 1989; 46(4):420-6. PubMed ID: 2672121
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunotoxins for treatment of leukemia and lymphoma.
    Uckun FM; Reaman GH
    Leuk Lymphoma; 1995 Jul; 18(3-4):195-201. PubMed ID: 8535182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumour therapy of solid tumours with ricin-antibody conjugates.
    Kanellos J; McKenzie IF; Pietersz GA
    Immunol Cell Biol; 1989 Apr; 67 ( Pt 2)():89-99. PubMed ID: 2786496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotoxins in cancer therapy: Review and update.
    Akbari B; Farajnia S; Ahdi Khosroshahi S; Safari F; Yousefi M; Dariushnejad H; Rahbarnia L
    Int Rev Immunol; 2017 Jul; 36(4):207-219. PubMed ID: 28282218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant single-chain and disulfide-stabilized Fv immunotoxins for cancer therapy.
    Niv R; Segal D; Reiter Y
    Methods Mol Biol; 2003; 207():255-68. PubMed ID: 12412479
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunotoxins: prospects and problems.
    Mendelsohn J
    J Clin Oncol; 1991 Dec; 9(12):2088-90. PubMed ID: 1960548
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunotoxin treatment of cancer.
    Pastan I; Hassan R; FitzGerald DJ; Kreitman RJ
    Annu Rev Med; 2007; 58():221-37. PubMed ID: 17059365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of recombinant immunotoxins for specific targeting of tumor-related peptides presented by MHC molecules.
    Cohen CJ; Denkberg G; Segal D; Reiter Y
    Methods Mol Biol; 2003; 207():269-82. PubMed ID: 12412480
    [No Abstract]   [Full Text] [Related]  

  • 30. Recombinant immunotoxins for treating cancer.
    FitzGerald DJ; Kreitman R; Wilson W; Squires D; Pastan I
    Int J Med Microbiol; 2004 Apr; 293(7-8):577-82. PubMed ID: 15149034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotoxins against solid tumors.
    Pirker R
    J Cancer Res Clin Oncol; 1988; 114(4):385-93. PubMed ID: 3045130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunotargeting of tumors: state of the art and prospects in 2000].
    Pèlegrin A; Xavier F; Barbet J; Bartholeyns J; Baty D; Buchegger F; Chatal JF; Dufief F; Gurreau D; Gruaz-Guyon A; Lamotte D; Leserman L; Mach JP; Robert B; Saccavini JC; Teillaud JL; Teulon I
    Bull Cancer; 2000 Nov; 87(11):777-91. PubMed ID: 11125287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
    Brinkmann U
    In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotoxins: an overview.
    Uhr JW
    Semin Cell Biol; 1991 Feb; 2(1):1-6. PubMed ID: 1954338
    [No Abstract]   [Full Text] [Related]  

  • 35. Antibody drug conjugates - Trojan horses in the war on cancer.
    Iyer U; Kadambi VJ
    J Pharmacol Toxicol Methods; 2011; 64(3):207-12. PubMed ID: 21843648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotoxicity of immunotoxins.
    Ilercil O; Laske DW; Walbridge S; Muaszko K; Oldfield EH; Youle RJ
    Mol Chem Neuropathol; 1994; 21(2-3):379-86. PubMed ID: 8086044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunotoxins (author's transl)].
    Richer G; Jansen FK; Gros P
    Nouv Presse Med; 1982 Apr; 11(17):1321-4. PubMed ID: 7079145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic engineering of immunotoxins.
    Chandler JC; Frankel AE; Tagge EP
    Semin Pediatr Surg; 1996 Aug; 5(3):206-11. PubMed ID: 8858768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotoxins and cancer therapy.
    Li Z; Yu T; Zhao P; Ma J
    Cell Mol Immunol; 2005 Apr; 2(2):106-12. PubMed ID: 16191416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates.
    Byers VS; Pimm MV; Scannon PJ; Pawluczyk I; Baldwin RW
    Cancer Res; 1987 Oct; 47(19):5042-6. PubMed ID: 3497715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.